AKER CHRISTOPHER RAY (Sr. VP & General Counsel) sold 46.8% of their position (43.63K shares) of REGULUS THERAPEUTICS INC. on the open market
Open‑market sale worth $55.1K — a major position exit. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 1/15/2025ACC: 0000950170-25-005882
Officer· Sr. VP & General Counsel
Since Jan 2019
-43.63K
Net shares
Net seller
$55.1K
Total sold
2
Open market trades
0B · 2S
2
Total transactions
43.63K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−38.55K
Price / share
$1.26
Trade value
$48.69K
% of position
41.4%
1/13/2025
93.18K→54.63K
Common Stock
Direct
Shares
−5.09K
Price / share
$1.26
Trade value
$6.43K
% of position
9.3%
1/14/2025
54.63K→49.55K
Total
Net shares
−43.63K
Net value
-$55.12K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/13/2025 | S · Sale | −38.55K | $1.26 | $48.69K | 41.4% | 93.18K | 54.63K |
| Common Stock Direct | 1/14/2025 | S · Sale | −5.09K | $1.26 | $6.43K | 9.3% | 54.63K | 49.55K |
| Total | −43.63K | -$55.12K | ||||||
Derivative Transactions0
No derivative transactions reported